Considering that differentiated tumor cells constitute the major population in GB tissues, the ability of ALDH1A3 to boost proliferation in differentiated progenies of GSCs further underscores the potential merit of ALDH1A3 inhibition as a therapeutic approach. Here, ALDH1A3 is linked to neoplasm.